Dx Deals: Illumina to Acquire SomaLogic from Standard BioTools for $425M
The deal is expected to be a big boost for Illumina’s next-generation sequencing platforms
Already a member? Log in here
Experts Discuss Opportunities and Challenges for NGS
Next-generation sequencing is reshaping how labs detect, understand, and manage disease
Already a member? Log in here
Making Complete Genome Sequencing Affordable, Accessible
Automation software uses advanced computational tools to generate gapless genome sequences in just a couple of days.
Already a member? Log in here
Illumina Faces Loss of Grail, Massive Fines
European Commission accuses sequencing giant of “jumping the gun” on Grail acquisition.
Professor Discusses His Work in Microfluidics, SARS-CoV-2 Sequencing
...
Already a member? Log in here